Anti-cancer medicaments
US7279576B2 · kind B2 · utility
54Cited by
11References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 24, 2003 |
| Grant date | Oct 9, 2007 |
| Priority date | — |
| Expiry date | Jun 3, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds and methods of using those compounds for the treatment of oncological conditions are provided. In a preferred embodiment, modulation of the activation states of abl or bcr-abl α-kinase proteins comprises the step of contacting the kinase proteins with the novel compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.